Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

Nonsense-mediated mRNA Decay

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

Nonsense-mediated mRNA Decay

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

RNA Editing

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients.

International journal of cancer·2026

Same author

Nivolumab in combination with lenvatinib in unresectable hepatocellular carcinoma: The IKF-t006/IMMUNIB translational phase-2 study.

European journal of cancer (Oxford, England : 1990)·2026

Same author

A Retrospective Multicenter Study Identifies a Similar Overall Survival of Patients After Liver Transplantation With Incidental Cholangiocarcinoma Compared to Hepatocellular Carcinoma.

Clinical transplantation·2026

Same author

Global biliary tract cancer genomics: From geographic patterns toward biological subtypes.

Journal of hepatology·2026

Same author

Perioperative approaches for patients with biliary tract cancer.

Nature reviews. Clinical oncology·2026

Same author

Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab.

Targeted oncology·2026

Search research articles

Related Experiment Video

Updated: May 18, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

A complex immunodeficiency is based on U1 snRNP-mediated poly(A) site suppression.

Jörg Langemeier¹, Eva-Maria Schrom, Alona Rabner

¹Cell and Virus Genetics Group, Institute for Virology, Hannover Medical School, Hannover, Germany.

The EMBO Journal

|September 13, 2012

Summary

A rare 3' untranslated region (UTR) mutation causing immunodeficiency creates a functional splice site. This site, recognized by U1 snRNP, suppresses p14 mRNA, revealing a novel disease mechanism.

More Related Videos

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads

Published on: December 9, 2020

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

Related Experiment Videos

Last Updated: May 18, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads

Published on: December 9, 2020

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

Area of Science:

Molecular Biology
Genetics
Immunology

Background:

Biallelic mutations in mRNA untranslated regions (UTRs) are rare causes of monogenetic diseases.
The mechanisms underlying UTR-mediated genetic disorders are often poorly understood.
A specific 3'UTR mutation was linked to a complex immunodeficiency syndrome due to reduced p14/robld3 mRNA levels.

Purpose of the Study:

To elucidate the molecular mechanism by which a 3'UTR mutation leads to p14 mRNA suppression and immunodeficiency.
To investigate the role of spliceosomal components in this novel disease mechanism.

Main Methods:

Mutation analysis of the p14/robld3 3'UTR.
Assessment of mRNA splicing and processing.
Investigation of U1 small nuclear ribonucleoprotein (snRNP) interactions.
Functional rescue experiments using histone processing signals.

Main Results:

The 3'UTR mutation creates a functional 5' splice site (SS).
Recognition of this aberrant SS by U1 snRNP leads to p14 mRNA suppression, independent of canonical splicing.
Histone processing signals could rescue p14 expression, indicating interference with poly(A)-site 3' end processing.
U1 snRNP appears to inhibit cleavage or poly(A) site recognition.

Conclusions:

This is the first reported case of a 3'UTR mutation creating a functional 5'SS that causes a monogenetic disease.
The findings highlight a novel mechanism of mRNA regulation and disease pathogenesis involving U1 snRNP.
The study underscores the detrimental role of U1 snRNP in suppressing intronic poly(A) sites when it interferes with essential mRNA biogenesis.